Here, we describe the ability of LOXO-292 to overcome acquired RET kinase domain mutations preclinically and in two patients with RET-altered cancers, one with acquired gatekeeper mutation resistance ...
Alterations of the RET receptor associated with human disease as well as analysis of knockout and transgenic animal models have revealed molecular mechanisms and pleiotropic effects of RET signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results